Prelude Capital Management’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,977
| Closed | -$272K | – | 1134 |
|
|
2024
Q4 | $272K | Buy |
+3,977
| New | +$272K | 0.02% | 728 |
|
|
2024
Q2 | – | Sell |
-6,801
| Closed | -$545K | – | 1161 |
|
|
2024
Q1 | $545K | Buy |
6,801
+4,382
| +181% | +$351K | 0.03% | 537 |
|
|
2023
Q4 | $265K | Buy |
2,419
+143
| +6% | +$15.7K | 0.02% | 690 |
|
|
2023
Q3 | $230K | Buy |
+2,276
| New | +$230K | 0.02% | 694 |
|
|
2020
Q4 | – | Sell |
-334
| Closed | -$26K | – | 915 |
|
|
2020
Q3 | $26K | Buy |
334
+57
| +21% | +$4.44K | ﹤0.01% | 973 |
|
|
2020
Q2 | $20K | Buy |
277
+2
| +0.7% | +$144 | ﹤0.01% | 940 |
|
|
2020
Q1 | $16K | Sell |
275
-520
| -65% | -$30.3K | ﹤0.01% | 688 |
|
|
2019
Q4 | $89K | Buy |
+795
| New | +$89K | ﹤0.01% | 780 |
|
|
2019
Q2 | – | Sell |
-121
| Closed | -$10K | – | 1320 |
|
|
2019
Q1 | $10K | Sell |
121
-93
| -43% | -$7.69K | ﹤0.01% | 1064 |
|
|
2018
Q4 | $14K | Buy |
+214
| New | +$14K | ﹤0.01% | 966 |
|
|
2017
Q2 | – | Sell |
-90
| Closed | -$4K | – | 1509 |
|
|
2017
Q1 | $4K | Buy |
+90
| New | +$4K | ﹤0.01% | 1350 |
|
|
2016
Q3 | – | Sell |
-3,030
| Closed | -$145K | – | 1543 |
|
|
2016
Q2 | $145K | Buy |
+3,030
| New | +$145K | 0.02% | 570 |
|
|
2014
Q4 | – | Sell |
-1,700
| Closed | -$63K | – | 1827 |
|
|
2014
Q3 | $63K | Buy |
+1,700
| New | +$63K | 0.01% | 1207 |
|
|
2013
Q4 | – | Sell |
-290
| Closed | -$10K | – | 1530 |
|
|
2013
Q3 | $10K | Buy |
+290
| New | +$10K | ﹤0.01% | 1163 |
|